ArticleTargeted oncology2024
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.
Taizo Uchimoto et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it